Ampio Pharmaceuticals Inc. opted against renewing the employment agreement of Gregory Gould, its CFO.
The biopharmaceutical company instead tapped its controller, Tom Chilcott, to take over Gould's duties on an interim basis.
Gould had been serving as the CFO of Ampio and Aytu BioScience Inc. since April 2015.